1. Home
  2. PDT vs CMPS Comparison

PDT vs CMPS Comparison

Compare PDT & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Premium Dividend Fund

PDT

John Hancock Premium Dividend Fund

HOLD

Current Price

$12.94

Market Cap

653.2M

Sector

Finance

ML Signal

HOLD

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$5.42

Market Cap

778.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDT
CMPS
Founded
N/A
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
653.2M
778.7M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
PDT
CMPS
Price
$12.94
$5.42
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$27.14
AVG Volume (30 Days)
102.1K
3.0M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.86
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.41
$2.25
52 Week High
$13.65
$8.90

Technical Indicators

Market Signals
Indicator
PDT
CMPS
Relative Strength Index (RSI) 35.34 33.53
Support Level $12.57 $4.78
Resistance Level $13.20 $7.02
Average True Range (ATR) 0.17 0.41
MACD -0.05 -0.18
Stochastic Oscillator 10.95 0.48

Price Performance

Historical Comparison
PDT
CMPS

About PDT John Hancock Premium Dividend Fund

John Hancock Premium Div Fund is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest capital growth. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, capital preferred securities, and short-term investments.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Share on Social Networks: